PBYI earnings: a negative outcome, -5.8%

On February 29, 2024, PUMA BIOTECHNOLOGY, INC. reached its earnings. The result was a negative outcome, and the stock moved -5.8% in the window around the event. It had already run +36.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.